BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19919615)

  • 1. Post-transfusion purpura caused by anti-HPA-3a antibodies that are only detectable using whole platelets in the platelet immunofluorescence test.
    Barba P; Pallarés P; Nogués N; Canals C; Gracia M; Vinyets I; Muñiz-Diaz E
    Transfus Med; 2010 Jun; 20(3):200-2. PubMed ID: 19919615
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
    Arber C; Bertrand G; Halter J; Boehlen F; Kaplan C; Gratwohl A
    Br J Haematol; 2007 Oct; 139(1):159-61. PubMed ID: 17854320
    [No Abstract]   [Full Text] [Related]  

  • 3. [Platelet antigens, antibodies and related clinical conditions].
    Muñiz Díaz E
    Sangre (Barc); 1991 Oct; 36(5):395-415. PubMed ID: 1840085
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a.
    Boehlen F; Kaplan C; de Moerloose P
    Vox Sang; 1998; 74(3):201-4. PubMed ID: 9595650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative studies to establish the first World Health Organization International Standard for detection of human antibody against human platelet antigen-3a.
    Berry J; Allen D; Porcelijn L; de Haas M; Kekomaki R; Kaplan C; Ouwehand WH; Metcalfe P
    Vox Sang; 2007 Nov; 93(4):309-15. PubMed ID: 18070275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal alloimmune thrombocytopenia due to an antibody against a labile component of human platelet antigen-3b (Bak b).
    Kataoka S; Kobayashi H; Chiba K; Nakamura M; Shinada S; Morita S; Lin M; Shibata Y
    Transfus Med; 2004 Dec; 14(6):419-23. PubMed ID: 15569236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet antigens and antibody detection.
    Metcalfe P
    Vox Sang; 2004 Jul; 87 Suppl1():82-6. PubMed ID: 15200612
    [No Abstract]   [Full Text] [Related]  

  • 8. [Refractoriness to platelet transfusion].
    Tsurumi H; Hara T; Moriwaki H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):332-4. PubMed ID: 9833505
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HPA-1a in a case of post-transfusion purpura: binding to antigen-negative platelets detected by adsorption/elution.
    Kiefel V; Schönberner-Richter I; Schilf K
    Transfus Med; 2005 Jun; 15(3):243-7. PubMed ID: 15943711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti Ko(a) as a cause of neonatal alloimmune thrombocytopenia].
    Kroll H; Muntean W; Kiefel V; Giptner A; Schlüter C; Santoso S; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1994; 32():244-6. PubMed ID: 9480100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet immunology. ELISA for detection of platelet antibodies, platelet-specific antigens and platelet glycoproteins.
    Taaning E
    Dan Med Bull; 1992 Aug; 39(4):343-54. PubMed ID: 1382006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet immunopathology and therapy: a Canadian Blood Services Research and Development Symposium.
    Tinmouth AT; Semple E; Shehata N; Branch DR
    Transfus Med Rev; 2006 Oct; 20(4):294-314. PubMed ID: 17008167
    [No Abstract]   [Full Text] [Related]  

  • 14. Ensuring quality in platelet immunology.
    Metcalfe P
    Vox Sang; 2007 Nov; 93(4):287-8. PubMed ID: 18070270
    [No Abstract]   [Full Text] [Related]  

  • 15. Consequences of transfusion of platelet antibody: a case report and literature review.
    Pavenski K; Webert KE; Goldman M
    Transfusion; 2008 Sep; 48(9):1981-9. PubMed ID: 18564398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
    Barz D; Gatzka E; Kollmorgen I
    Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of HPA-1a (PlA1)-negative platelets in a patient with post-transfusion purpura.
    Loren AW; Abrams CS
    Am J Hematol; 2004 Jul; 76(3):258-62. PubMed ID: 15224362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile nonhaemolytic transfusion reaction caused by antibodies against human platelet antigen 5a.
    Tazzari PL; Bontadini A; Zamagni C; Ricci F; Fruet F; Iannelli S; Conte R
    Transfus Med; 2005 Oct; 15(5):443-4. PubMed ID: 16202061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-reactive platelet antibodies in post-transfusion purpura.
    Taaning E; Tønnesen F
    Vox Sang; 1999; 76(2):120-3. PubMed ID: 10085529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of platelet alloantibody in multiply-transfused haematology patients.
    Linn YC; Prakash P; Ong YW
    Ann Acad Med Singap; 1995 Mar; 24(2):305-11. PubMed ID: 7653976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.